Indian pharmaceutical market

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

NATCO Pharma (NSE: NATCOPHARM) launches cheapest semaglutide in India at Rs 1,290 on Day 1 of patent expiry

NATCO Pharma launches generic semaglutide in India at INR 1,290 on Day 1 of patent expiry. What it means for GLP-1 markets. Read the full analysis.

bySrinath

March 20, 2026

Torrent Pharmaceuticals licenses Vonoprazan from Takeda to treat GERD in India

Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan,…

byPallavi Madhiraju

June 6, 2024

The Latest

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

NATCO Pharma (NSE: NATCOPHARM) launches cheapest semaglutide in India at Rs 1,290 on Day 1 of patent expiry

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

Genesis Minerals (ASX: GMD) launches A$5.6bn Vault bid as Regis faces five-day test

Solstice to buy Element Solutions for $14.5bn as AI materials strategy faces investor test

Ipsen agrees €700m Memo Therapeutics deal as acquisition spree accelerates

Israel cabinet challenges Supreme Court media ruling as constitutional crisis fears return